
Ultra-Low-Dose Immunotherapy May Benefit Cancer Patients in Low-Resource Countries
Introducción CHICAGO — Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients

Pennsylvania officials have reported a fourth measles-associated death. Detalles del caso El último fallecimiento involucra a un residente de 18…
Read more →



Introducción CHICAGO — Triple oral metronomic chemotherapy combined with ultra-low-dose immunotherapy (TMC-I) may be a promising first-line treatment for patients

Introducción The name of a condition that affects between 6-10% of all reproductive-age women was recently changed from PCOS (polycystic

As the Trump administration continues to target gender-affirming care for youth, the Senate Health, Education, Labor and Pensions (HELP) committee

Introducción For U.S. kids born after the rotavirus vaccine was introduced, recommendations against administration in the neonatal intensive care unit

Investigational Apitegromab Investigational apitegromab, a selective myostatin activation inhibitor, effectively preserved lean mass when combined with tirzepatide (Zepbound) in a